Proteins and Peptides
27 March 2013
Amarantus BioScience Reports Positive MANF Data in Neuroprotection Animal Models of Parkinson’s Disease26 March 2013
BioSpecifics Technologies Corp. Announces Positive Top-line Data from XIAFLEX Phase IIa Study for Frozen Shoulder20 March 2013
Adocia announces its phase III development program for the treatment of diabetic foot ulcer18 March 2013
People with type 2 diabetes achieve 6% weight loss with liraglutide 3 mg in phase 3a obesity trial6 March 2013
Tarix Pharmaceuticals’ Peptide Technology Stimulates Revascularization Following Ischemia26 February 2013
Baxter Submits Application for FDA Approval of FEIBA NF for Prophylactic Use in Hemophilia A and B Patients with Inhibitors25 February 2013
Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSINews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports